Ovarian cancer screening in Korea: What You Need to Know

Ovarian cancer is known as a “silent” disease because symptoms often appear in advanced stages. Early detection significantly improves treatment outcomes, making regular screening essential—especially for women with family history, BRCA gene mutations, or persistent abdominal symptoms. In Korea, ovarian cancer screening is performed using high-resolution imaging, tumor marker testing, and personalized risk assessment. Patients receive thorough evaluations in modern clinics with supportive, English-speaking staff.


Ovarian Cancer Screening Methods in Korea

1. Transvaginal Ultrasound (TVUS)

  • The most common imaging method for visualizing ovarian structures
  • Detects abnormal masses, cysts, or changes in ovarian size or shape
  • Non-invasive and performed within minutes during a pelvic exam

2. Blood Tests for Tumor Markers

  • CA-125: Elevated in many cases of ovarian cancer
  • HE4: Used in combination with CA-125 to improve accuracy
  • ROMA (Risk of Ovarian Malignancy Algorithm): Combines marker results with menopausal status to assess cancer risk

3. Pelvic Exam and Medical History Review

  • Physical examination to assess pelvic organs
  • Review of symptoms (bloating, abdominal pain, early satiety) and family cancer history

4. Genetic Testing (if indicated)

  • BRCA1 and BRCA2 gene mutation screening for women with strong family history of ovarian or breast cancer
  • Helps determine long-term risk and guide future prevention or screening strategies


Why Choose Korea for Ovarian Cancer Screening?

  • Advanced diagnostic imaging and comprehensive gynecologic evaluation in one visit
  • Access to genetic counseling and BRCA testing at top-tier hospitals
  • English-speaking specialists in women’s clinics across Gangnam, Apgujeong, and Myeongdong
  • Short wait times and immediate results for peace of mind
  • Proactive approach to early detection, especially for high-risk women


Cost of Ovarian Cancer Screening in Korea

  • Transvaginal ultrasound: ₩100,000 to ₩200,000
    (approx. $75 to $150 USD)
  • CA-125 and HE4 blood tests: ₩100,000 to ₩250,000
    (approx. $75 to $185 USD)
  • ROMA score analysis: ₩150,000 to ₩300,000
    (approx. $110 to $220 USD)
  • BRCA gene testing (if needed): ₩500,000 to ₩1,000,000
    (approx. $370 to $750 USD)
  • Full screening package: ₩300,000 to ₩600,000
    (approx. $220 to $450 USD)

Many clinics offer bundled screening packages with ultrasound, tumor markers, and consultation included.


Recovery and Follow-Up

  • Ovarian cancer screening is non-invasive and requires no downtime
  • Patients typically receive results on the same day or within a few days
  • Follow-up imaging or gynecologic oncology referral arranged if abnormalities are found
  • Annual or semi-annual screening is recommended for high-risk individuals


Conclusion

Korea provides advanced, accessible ovarian cancer screening tailored to each woman’s risk profile. With a focus on early detection and patient-centered care, Korean clinics deliver fast, accurate results in comfortable, modern settings. Whether for peace of mind or ongoing monitoring, ovarian screening in Korea offers high-quality care with internationally trusted standards.